Canterbury DHB


Haemophilia B

Aim: to prevent spontaneous bleeding.

This is generally achieved by a peak factor IX of 40% (assume half-life of 20 hrs).

Treatment is normally given twice weekly.

About this Canterbury DHB document (5311):

Document Owner:

Mark Smith (see Who's Who)

Issue Date:

August 2016

Next Review:

August 2019


Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 5311